NEW YORK (GenomeWeb News) – Life Technologies today announced that it has acquired Dutch firm BAC BV for an undisclosed sum.

BAC makes protein purification products and will expand Life Tech's portfolio in bioprocessing by adding the firm's affinity ligands to Life Tech's Poros brand of chromatography resins for purification of therapeutic products. The new technologies also complement Life Tech's Gibco brand of cell culture media products and the Applied Biosystems SEQ rapid molecular kits for containment and impurity testing of biotherapeutic products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.